 RALEIGH, NC ACCESSWIRE July 6, 2020 9 Meters Biopharma, Inc. NMTR, a clinical-stage rare and unmet needs-focused gastroenterology company, announced today the Company has appointed Michael T. Constantino to its board of directors. Mr. Constantino is a North Carolina certified public accountant who served as an Ernst Young LLP assurance partner for more than 30 years, serving public and private entrepreneurial companies across several industries, including biotechnology, pharmaceuticals, contract research and technology. Of note, he has acted as a coordinating partner with the gastrointestinal pharmaceutical company, Salix Pharmaceuticals acquired by Valeant Pharmaceuticals, and contract pharmaceutical manufacturer, Patheon acquired by Thermo Fisher Scientific. 